REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,075,678 | +7.4% | 10,550 | +5.0% | 0.07% | +169.2% |
| Q1 2021 | $1,002,000 | +34.5% | 10,050 | +31.3% | 0.03% | -27.8% |
| Q3 2020 | $745,000 | +1141.7% | 7,652 | +1887.5% | 0.04% | +1100.0% |
| Q2 2020 | $60,000 | -98.5% | 385 | -98.0% | 0.00% | -98.0% |
| Q4 2019 | $3,971,000 | -8.2% | 19,423 | -63.9% | 0.15% | -22.6% |
| Q3 2019 | $4,326,000 | +7.4% | 53,876 | +26.2% | 0.20% | -1.5% |
| Q2 2019 | $4,028,000 | +1479.6% | 42,694 | +244.0% | 0.20% | +942.1% |
| Q1 2018 | $255,000 | – | 12,412 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |